AAPS PharmSciTech

, Volume 14, Issue 1, pp 301–311

Cyclodextrin-Crosslinked Poly(Acrylic Acid): Adhesion and Controlled Release of Diflunisal and Fluconazole from Solid Dosage Forms

  • Marguerite J. Kutyła
  • Michael W. Boehm
  • Jason R. Stokes
  • P. Nicholas Shaw
  • Nigel M. Davies
  • Ross P. McGeary
  • Jonathan Tuke
  • Benjamin P. Ross
Research Article

Abstract

The controlled release of diflunisal and fluconazole from tablets made of novel polymers, poly(acrylic acid) (PAA) crosslinked with either β-cyclodextrin (βCD) or hydroxypropyl-βCD (HPβCD), was investigated and Carbopol 934P (Carbopol) was used as a highly crosslinked PAA for comparison. Diflunisal strongly associates with βCD-PAA and HPβCD-PAA polymers (Ka of 486 and 6,055 M−1 respectively); thus, it was physically mixed into the conjugates and also precomplexed to identify whether decomplexation has any influence on release kinetics. Fluconazole has poor complexing ability (Ka of 34 M−1 with HPβCD-PAA); thus, it was only tested as a physical mixture. Swelling and adhesion studies were conducted on all tablet combinations and adhesivity of the CD-PAA polymer tablets was maintained. Diflunisal release was much slower from HPβCD-PAA tablets than from βCD-PAA, suggesting that a higher degree of complexation retards release. The precomplexed diflunisal release was also slower than the physically mixed diflunisal of the corresponding conjugate. The release closely followed zero-order kinetics for HPβCD-PAA, but was more sigmoidal for βCD-PAA and especially Carbopol. Conversely, poorly associating fluconazole released in almost exactly the same way across both polymers and Carbopol, indicating that the release kinetics of poorly associating drugs are not influenced by the presence of cyclodextrins. In view of the varying profiles and release rates shown with diflunisal for the different polymers, the fluconazole data support the concept that adequate complexation can indeed modulate the release kinetics of drugs.

Key words

controlled release cyclodextrin diflunisal fluconazole poly(acrylic acid) 

Supplementary material

12249_2012_9903_MOESM1_ESM.docx (134 kb)
ESM 1(DOCX 134 kb)

References

  1. 1.
    Miro A, Rondinone A, Nappi A, Ungaro F, Quaglia F, La Rotonda MI. Modulation of release rate and barrier transport of Diclofenac incorporated in hydrophilic matrices: role of cyclodextrins and implications in oral drug delivery. Eur J Pharm Biopharm. 2009;72(1):76–82.PubMedCrossRefGoogle Scholar
  2. 2.
    Peppas NA, Bures P, Leobandung W, Ichikawa H. Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm. 2000;50(1):27–46.PubMedCrossRefGoogle Scholar
  3. 3.
    Cui F, He C, He M, Tang C, Yin L, Qian F, et al. Preparation and evaluation of chitosan-ethylenediaminetetraacetic acid hydrogel films for the mucoadhesive transbuccal delivery of insulin. J Biomed Mater Res. 2009;89A(4):1063–71.CrossRefGoogle Scholar
  4. 4.
    Sudhakar Y, Kuotsu K, Bandyopadhyay AK. Buccal bioadhesive drug delivery—a promising option for orally less efficient drugs. J Contr Release. 2006;114(1):15–40.CrossRefGoogle Scholar
  5. 5.
    Senel S, Kremer M, Nagy K, Squier C. Delivery of bioactive peptides and proteins across oral (buccal) mucosa. Curr Pharm Biotechnol. 2001;2(2):175–86.PubMedCrossRefGoogle Scholar
  6. 6.
    Kutyla MJ, Lambert LK, Davies NM, McGeary RP, Shaw PN, Ross BP. Cyclodextrin-crosslinked poly(acrylic acid): synthesis, physicochemical characterization and controlled release of diflunisal and fluconazole from hydrogels. Int J Pharm. doi:10.1016/j.ijpharm.2013.01.005
  7. 7.
    Bongaerts J, Rossetti D, Stokes J. The lubricating properties of human whole saliva. Tribol Lett. 2007;27(3):277–87.CrossRefGoogle Scholar
  8. 8.
    Mortazavi SA, Smart JD. An investigation of some factors influencing the in vitro assessment of mucoadhesion. Int J Pharm. 1995;116:223–30.CrossRefGoogle Scholar
  9. 9.
    Maggi L, Carena ML, Torre ML, Giunchedi P, Conte U. In vitro/ex vivo methods for the evaluation of bioadhesive polymers. A preliminary study. STP Pharma. 1994;4:343–8.Google Scholar
  10. 10.
    Koh GL, Tucker IG. Variability in the phenol-sulphuric acid assay for sodium carboxymethylcellulose. Int J Pharm. 1986;34:183–4.CrossRefGoogle Scholar
  11. 11.
    Jones DS, Muldoon BCO, Woolfson AD, Sanderson FD. An examination of the rheological and mucoadhesive properties of poly(acrylic acid) organogels designed as platforms for local drug delivery to the oral cavity. J Pharm Sci. 2007;96(10):2632–46.PubMedCrossRefGoogle Scholar
  12. 12.
    Munasur AP, Govender T, Mackraj I. Using an experimental design to identify and quantify the effects of environment related test parameters on the in vitro mucoadhesivity testing of a propanolol buccal tablet. Drug Dev Ind Pharm. 2007;33(7):709–16.PubMedCrossRefGoogle Scholar
  13. 13.
    Shanker G, Kumar C, Gonugunta C, Kumar B, Veerareddy P. Formulation and evaluation of bioadhesive buccal drug delivery of tizanidine hydrochloride tablets. AAPS PharmSciTech. 2009;10(2):530–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Patel VM, Prajapati BG, Patel MM. Effect of hydrophilic polymers on buccoadhesive Eudragit patches of propranolol hydrochloride using factorial design. AAPS PharmSciTech. 2007;8(2):E1–7.CrossRefGoogle Scholar
  15. 15.
    Bonacucina G, Cespi M, Misici-Falzi M, Palmieri GF. Rheological, adhesive and release characterisation of semisolid Carbopol/tetraglycol systems. Int J Pharm. 2006;307:129–40.PubMedCrossRefGoogle Scholar
  16. 16.
    Bonacucina G, Martelli S, Palmieri GF. Rheological, mucoadhesive and release properties of Carbopol gels in hydrophilic cosolvents. Int J Pharm. 2004;282:115–30.PubMedCrossRefGoogle Scholar
  17. 17.
    Tamburic S, Craig DQM. A comparison of different in vitro methods for measuring mucoadhesive performance. Eur J Pharm Biopharm. 1997;44:159–67.CrossRefGoogle Scholar
  18. 18.
    Bromberg L, Temchenko M, Alakhov V, Hatton TA. Bioadhesive properties and rheology of polyether-modified poly(acrylic acid) hydrogels. Int J Pharm. 2004;282:45–60.PubMedCrossRefGoogle Scholar
  19. 19.
    Anlar S, Capan Y, Guven O, Gogus A, Dalkara T, Hincal AA. Formulation and in vitro-in vivo evaluation of buccoadhesive morphine sulfate tablets. Pharm Res. 1994;11(2):231–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Bouckaert S, Lefebvre RA, Remon JP. In vitro/in vivo correlation of the bioadhesive properties of a buccal bioadhesive miconazole slow-release tablet. Pharm Res. 1993;10(6):853–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Laulicht B, Cheifetz P, Tripathi A, Mathiowitz E. Are in vivo gastric bioadhesive forces accurately reflected by in vitro experiments? J Contr Release. 2009;134(2):103–10.CrossRefGoogle Scholar
  22. 22.
    Jabbari E, Wisniewski N, Peppas NA. Evidence of mucoadhesion by chain interpenetration at a poly(acrylic acid)/mucin interface using ATR-FTIR spectroscopy. J Contr Release. 1993;26(2):99–108.CrossRefGoogle Scholar
  23. 23.
    Saiano F, Pitarresi G, Cavallaro G, Licciardi M, Giammona G. Evaluation of mucoadhesive properties of α,β-poly(N-hydroxyethyl)-dl-aspartamide and α,β-poly(aspartylhydrazide) using ATR-FTIR spectroscopy. Polymer. 2002;43(23):6281–6.CrossRefGoogle Scholar
  24. 24.
    Mortazavi SA. An in vitro assessment of mucus/mucoadhesive interactions. Int J Pharm. 1995;124(2):173–82.CrossRefGoogle Scholar
  25. 25.
    Patel MM, Smart JD, Nevell TG, Ewen RJ, Eaton PJ, Tsibouklis J. Mucin/poly(acrylic acid) interactions: a spectroscopic investigation of mucoadhesion. Biomacromolecules. 2003;4(5):1184–90.PubMedCrossRefGoogle Scholar
  26. 26.
    Hassan EE, Gallo JM. A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength. Pharm Res. 1990;7(5):491–5.Google Scholar
  27. 27.
    Rossi S, Bonferoni MC, Lippoli G, Bertoni M, Ferrari F, Caramella C, et al. Influence of mucin type on polymer-mucin rheological interactions. Biomaterials. 1995;16(14):1073–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Lehr C-M, Boddé HE, Bouwstra JA, Junginger HE. A surface energy analysis of mucoadhesion II. Prediction of mucoadhesive performance by spreading coefficients. Eur J Pharm Sci. 1993;1(1):19–30.CrossRefGoogle Scholar
  29. 29.
    Rillosi M, Buckton G. Modelling mucoadhesion by use of surface energy terms obtained from the Lewis Acid—Lewis Base Approach. II. Studies on anionic, cationic, and unionisable polymers. Pharm Res. 1995;12(5):669–75.PubMedCrossRefGoogle Scholar
  30. 30.
    Grabovac V, Guggi D, Bernkop-Schnürch A. Comparison of the mucoadhesive properties of various polymers. Adv Drug Deliv Rev. 2005;57(11):1713–23.PubMedCrossRefGoogle Scholar
  31. 31.
    Gu JM, Robinson JR, Leung SH. Binding of acrylic polymers to mucin/epithelial surfaces: structure-property relationships. Crit Rev Ther Drug Carrier Syst. 1988;5(1):21–67.PubMedGoogle Scholar
  32. 32.
    Stokes JR, Davies GA. Viscoelasticity of human whole saliva collected after acid and mechanical stimulation. Biorheology. 2007;44(3):141–60.PubMedGoogle Scholar
  33. 33.
    Stokes JR. Rheology of industrially relevant microgels. In: Fernandez-Nieves A, Wyss HM, Mattsson J, Weitz DA, editors. Microgel suspensions: fundamentals and applications. Germany: Wiley-VCH Verlag GmbH & Co. KGaA; 2011. p 327–53.Google Scholar
  34. 34.
    Boscaini E, Alexander M, Prazeller P, Mark T. Investigation of fundamental physical properties of a polydimethylsiloxane (PDMS) membrane using a proton transfer reaction mass spectrometer (PTRMS). Int J Mass Spectrom. 2004;239(2–3):179–86.Google Scholar
  35. 35.
    Wang PY. Evidence of hydrophobic interaction in adhesion to tissue. Nature. 1974;249:367–8.PubMedCrossRefGoogle Scholar
  36. 36.
    de Vicente J, Stokes JR, Spikes HA. Soft lubrication of model hydrocolloids. Food Hydrocolloids. 2006;20(4):483–91.CrossRefGoogle Scholar
  37. 37.
    Lubrizol. Lubrizol pharmaceutical polymers for controlled release tablets and capsules. Lubrizol Advanced Materials I. Cleveland, Ohio; 2010. p 1–9.Google Scholar
  38. 38.
    Elkheshen S. Interaction of verapamil hydrochloride with Carbopol 934P and its effect on the release rate of the drug and the water uptake of the polymer matrix. Drug Dev Ind Pharm. 2001;27(9):925.PubMedCrossRefGoogle Scholar
  39. 39.
    Flick EW. Cosmetic and toiletry formulations, volume 7. 2nd ed. Norwich: William Andrew Publishing/Noyes; 1999.Google Scholar
  40. 40.
    Langenbucher F. Linearization of dissolution rate curves by the Weibull distribution. J Pharm Pharmacol. 1972;24(12):979–81.PubMedCrossRefGoogle Scholar
  41. 41.
    Adams E, Coomans D, Smeyers-Verbeke J, Massart DL. Non-linear mixed effects models for the evaluation of dissolution profiles. Int J Pharm. 2002;240(1–2):37–53.PubMedCrossRefGoogle Scholar
  42. 42.
    Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123–33.PubMedCrossRefGoogle Scholar
  43. 43.
    Koester LS, Ortega GG, Mayorga P, Bassani VL. Mathematical evaluation of in vitro release profiles of hydroxypropylmethylcellulose matrix tablets containing carbamazepine associated to β-cyclodextrin. Eur J Pharm Biopharm. 2004;58(1):177–9.PubMedCrossRefGoogle Scholar
  44. 44.
    Macheras P, Dokoumetzidis A. On the heterogeneity of drug dissolution and release. Pharm Res. 2000;17(2):108–12.PubMedCrossRefGoogle Scholar
  45. 45.
    Lánský P, Weiss M. Classification of dissolution profiles in terms of fractional dissolution rate and a novel measure of heterogeneity. J Pharm Sci. 2003;92(8):1632–47.PubMedCrossRefGoogle Scholar
  46. 46.
    Elkoshi Z. On the variability of dissolution data. Pharm Res. 1997;14(10):1355–62.PubMedCrossRefGoogle Scholar
  47. 47.
    Papadopoulou V, Kosmidis K, Vlachou M, Macheras P. On the use of the Weibull function for the discernment of drug release mechanisms. Int J Pharm. 2006;309(1–2):44–50.PubMedCrossRefGoogle Scholar
  48. 48.
    Ritger PL, Peppas NA. A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Contr Release. 1987;5(1):23–36.CrossRefGoogle Scholar
  49. 49.
    Colombo P, Bettini R, Santi P, De Ascentiis A, Peppas NA. Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transport. J Contr Release. 1996;39(2–3):231–7.CrossRefGoogle Scholar
  50. 50.
    Harland RS, Gazzaniga A, Sangalli ME, Colombo P, Peppas NA. Drug/polymer matrix swelling and dissolution. Pharm Res. 1988;5(8):488–94.PubMedCrossRefGoogle Scholar
  51. 51.
    Colombo P, Bettini R, Massimo G, Catellani PL, Santi P, Peppas NA. Drug diffusion front movement is important in drug release control from swellable matrix tablets. J Pharm Sci. 1995;84(8):991–7.PubMedCrossRefGoogle Scholar
  52. 52.
    Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15(1):25–35.CrossRefGoogle Scholar
  53. 53.
    Catellani P, Vaona G, Plazzi P, Colombo P. Compressed matrices: formulation and drug release kinetics. Acta Pharmaceutica Technologica. 1988;34:38–41.Google Scholar
  54. 54.
    Möckel JE, Lippold BC. Zero-order drug release from hydrocolloid matrices. Pharm Res. 1993;10(7):1066–70.PubMedCrossRefGoogle Scholar
  55. 55.
    Fischel-Ghodsian F, Newton JM. Analysis of drug release kinetics from degradable polymeric devices. J Drug Target. 1993;1(1):51–7.PubMedCrossRefGoogle Scholar
  56. 56.
    Hopfenberg HB. Controlled release from erodible slabs, cylinders, and spheres. In: Controlled release polymeric formulations: American Chemical Society; 1976. vol 33 p. 26–32.Google Scholar
  57. 57.
    Zugasti ME, Zornoza A, del Mar Goni M, Isasi JR, Velaz I, Martin C, et al. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets. Drug Dev Ind Pharm. 2009;35(10):1264–70.PubMedCrossRefGoogle Scholar
  58. 58.
    Koester LS, Xavier CR, Mayorga P, Bassani VL. Influence of β-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets. Eur J Pharm Biopharm. 2003;55(1):85–91.PubMedCrossRefGoogle Scholar
  59. 59.
    Pose-Vilarnovo B, Rodriguez-Tenreiro C, dos Santos JFR, Vazquez-Doval J, Concheiro A, Alvarez-Lorenzo C, et al. Modulating drug release with cyclodextrins in hydroxypropyl methylcellulose gels and tablets. J Contr Release. 2004;94(2–3):351–63.CrossRefGoogle Scholar
  60. 60.
    Salmaso S, Semenzato A, Bersani S, Matricardi P, Rossi F, Caliceti P. Cyclodextrin/PEG based hydrogels for multi-drug delivery. Int J Pharm. 2007;345(1–2):42–50.PubMedCrossRefGoogle Scholar
  61. 61.
    Caliceti P, Salmaso S, Semenzato A, Carofiglio T, Fornasier R, Fermeglia M, et al. Synthesis and physicochemical characterization of folate—cyclodextrin bioconjugate for active drug delivery. Bioconjug Chem. 2003;14(5):899–908.PubMedCrossRefGoogle Scholar
  62. 62.
    Nielsen AL, Madsen F, Larsen KL. Cyclodextrin modified hydrogels of PVP/PEG for sustained drug release. Drug Deliv. 2009;16(2):92–101.PubMedCrossRefGoogle Scholar
  63. 63.
    Mitchell K, Ford JL, Armstrong DJ, Elliott PNC, Hogan JE, Rostron C. The influence of drugs on the properties of gels and swelling characteristics of matrices containing methylcellulose or hydroxypropylmethylcellulose. Int J Pharm. 1993;100(1–3):165–73.CrossRefGoogle Scholar
  64. 64.
    Dahlberg C, Fureby A, Schuleit M, Dvinskikh SV, Furó I. Polymer mobilization and drug release during tablet swelling. A 1H NMR and NMR microimaging study. J Contr Release. 2007;122(2):199–205.CrossRefGoogle Scholar
  65. 65.
    Peppas NA, Wright SL. Solute diffusion in poly(vinyl alcohol)/poly(acrylic acid) interpenetrating networks. Macromolecules. 1996;29(27):8798–804.CrossRefGoogle Scholar
  66. 66.
    Smart JD, Mortazavi SA. An investigation of the pH within the gel layer of a hydrating poly(acrylic acid) compact. J Pharm Pharmacol. 1995;47:1099.Google Scholar
  67. 67.
    Canal T, Peppas NA. Correlation between mesh size and equilibrium degree of swelling of polymeric networks. J Biomed Mater Res. 1989;23(10):1183–93.PubMedCrossRefGoogle Scholar
  68. 68.
    Vergnaud JM. Liquid transport controlled release processes in polymeric materials: applications to oral dosage forms. Int J Pharm. 1993;90(2):89–94.CrossRefGoogle Scholar
  69. 69.
    Warren SJ, Kellaway IW. The synthesis and in vitro characterization of the mucoadhesion and swelling of poly(acrylic acid) hydrogels. Pharm Dev Technol. 1998;3(2):199–208.PubMedCrossRefGoogle Scholar
  70. 70.
    Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Contr Release. 1987;5(1):37–42.CrossRefGoogle Scholar
  71. 71.
    Fakes MG, Dali MV, Haby TA, Morris KR, Varia SA, Serajuddin ATM. Moisture sorption behavior of selected bulking agents used in lyophilized products. PDA J Pharm Sci Technol. 2000;54(2):144–9.PubMedGoogle Scholar
  72. 72.
    Llabot JM, Manzo RH, Allemandi DA. Drug release from carbomer:carbomer sodium salt matrices with potential use as mucoadhesive drug delivery system. Int J Pharm. 2004;276(1–2):59–66.PubMedCrossRefGoogle Scholar
  73. 73.
    Bernkop-Schnürch A, Humenberger C, Valenta C. Basic studies on bioadhesive delivery systems for peptide and protein drugs. Int J Pharm. 1998;165(2):217–25.CrossRefGoogle Scholar
  74. 74.
    Bashaiwoldu AB, Podczeck F, Newton JM. A study on the effect of drying techniques on the mechanical properties of pellets and compacted pellets. Eur J Pharm Sci. 2004;21(2–3):119–29.PubMedCrossRefGoogle Scholar
  75. 75.
    Siepmann F, Le Brun V, Siepmann J. Drugs acting as plasticizers in polymeric systems: a quantitative treatment. J Contr Release. 2006;115(3):298–306.CrossRefGoogle Scholar
  76. 76.
    Siepmann J, Lecomte F, Bodmeier R. Diffusion-controlled drug delivery systems: calculation of the required composition to achieve desired release profiles. J Contr Release. 1999;60(2–3):379–89.CrossRefGoogle Scholar
  77. 77.
    Jacques Y, Buri P. An investigation of the physical behaviour of moisture-activated mucoadhesive hydrogels upon contact with biological and non-biological substrates. Pharm Acta Helv. 1997;72(4):225–32.PubMedCrossRefGoogle Scholar
  78. 78.
    Peppas NA, Buri P. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J Contr Release. 1985;2:257–75.CrossRefGoogle Scholar
  79. 79.
    Park H, Robinson JR. Physico-chemical properties of water insoluble polymers important to mucin/epithelial adhesion. J Contr Release. 1985;2:41–57.CrossRefGoogle Scholar
  80. 80.
    Henriksen I, Green KL, Smart JD, Smistad G, Karlsen J. Bioadhesion of hydrated chitosans: an in vitro and in vivo study. Int J Pharm. 1996;145(1–2):231–40.CrossRefGoogle Scholar
  81. 81.
    Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev. 2005;57(11):1556–68.PubMedCrossRefGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2013

Authors and Affiliations

  • Marguerite J. Kutyła
    • 1
  • Michael W. Boehm
    • 2
  • Jason R. Stokes
    • 2
  • P. Nicholas Shaw
    • 1
  • Nigel M. Davies
    • 1
  • Ross P. McGeary
    • 1
    • 3
  • Jonathan Tuke
    • 4
  • Benjamin P. Ross
    • 1
  1. 1.School of PharmacyThe University of QueenslandBrisbaneAustralia
  2. 2.School of Chemical EngineeringThe University of QueenslandBrisbaneAustralia
  3. 3.School of Chemistry and Molecular BiosciencesThe University of QueenslandBrisbaneAustralia
  4. 4.School of Mathematical SciencesUniversity of AdelaideAdelaideAustralia

Personalised recommendations